Cerner Corporation (CERN) shares rallied 22.66% in after-hours on Thursday, December 16, 2021, and closed the daily trading at $97.50. Even in the regular trading session, CERN’s stock gained 0.72%. CERN shares have risen 2.70% over the last 12 months, and they have moved up 5.78% in the past week. Over the past three months, the stock has gained 5.93%, while over the past six months, it has gained 0.88%.
Let’s see what is the latest news about the company?
Oracle working on a deal to acquire CERN
On Dec 16, 2021, according to the Wall Street Journal, Enterprise software maker Oracle is in talks to buy electronic medical records company Cerner (CERN) in a deal that could be valued at $30 billion.
If the deal happens, it will be the biggest ever deal for Oracle, which has a market value of more than $280 billion. The transaction could bring Oracle a portfolio of health data to train and improve its artificial intelligence-based cloud services, boosting its presence in the healthcare sector.
Cerner is the biggest seller of electronic health record software in the United States after Epic Systems Corp.
CERN Dividend Declaration
On December 10, 2021, the board of directors of Cerner Corporation (CERN), declared a cash dividend to stockholders of $0.27 per issued and outstanding share, up 23 percent from the prior quarterly dividend of $0.22. The cash dividend will be payable on January 11, 2022, to shareholders of record as of the close of business on December 27, 2021.
CERN new appointment
On November 16, 2021, Cerner Corporation (CERN), appointed Nasim Afsar, MD, MBA, MHM, as the company’s first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner’s more than 1,000 healthcare professionals who provide insight and guidance to product development and improve the lives of patients and caregivers.
CERN latest financial results
On October 29, 2021, Cerner Corporation (CERN) announced results for the 2021 third quarter that ended September 30, 2021.
Q3 2021 financial highlights
- CERN reported total revenue of $1.468 billion in Q3 2021 compared to $1.369 billion in the third quarter of 2020.
- The total cost of revenue was $251.1 million in Q3 2021 compared to $231.9 million in Q3 2020.
- Total operating expenses were $991.9 million in Q3 2021 compared to $941.8 million in Q3 2020.
- It earned a net income of $175.8 million in Q3 2021 compared to $356.7 million in Q3 2020.
The Cerner Stock skyrocketed after speculations that Oracle is interested in by the company. We can see it to further surge in the coming trading session.